{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-035736","form_type":"8-K","ticker":"SER","cik":"0001708599","company_name":"Serina Therapeutics, Inc.","filed_at":"2022-12-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.788579+00:00","generated_at":"2026-06-21T03:26:19.379524+00:00","sec_items":["2.03","3.02","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"AgeX borrows additional $1M from Juvenescence, total $12.66M; issues warrants for 847K shares at $0.59","bullets":["Borrowed additional $1,000,000 under Secured Convertible Note with Juvenescence. Total outstanding balance now $12,660,000.","Remaining $500,000 line of credit may be drawn subject to Juvenescence's discretion through first anniversary date.","In connection with draw, will issue warrants to purchase 847,457 shares of common stock at $0.59 per share.","Secured Note matures on February 14, 2024; origination fee 4% per draw plus additional 4% after 12 months."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-035736","json":"https://secwatch.observer/filing/0001493152-22-035736.json","markdown":"https://secwatch.observer/filing/0001493152-22-035736.md","text":"https://secwatch.observer/filing/0001493152-22-035736.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1708599/000149315222035736/0001493152-22-035736-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1708599/000149315222035736/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T03:26:19.379524+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9e834d2415ba5a4bd3b7a927882f8bf752775163","claim":"Serina Therapeutics, Inc. incurred convertible notes of $1,000,000 with Juvenescence Limited at 4% of the amount each draw of loan funds, which will accrue as each draw is fund maturing February 14, 2024.","evidence_excerpt":"On December 14, 2022, AgeX borrowed an additional $1,000,000 under the Secured Convertible Promissory Note (the “Secured Note”) dated as of February 14, 2022 with Juvenescence Limited (“Juvenescence”).","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/1708599/000149315222035736/0001493152-22-035736-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Principal","value":"$1,000,000"},{"label":"Counterparty","value":"Juvenescence Limited"},{"label":"Rate","value":"4% of the amount each draw of loan funds, which will accrue as each draw is fund"},{"label":"Maturity","value":"February 14, 2024"},{"label":"Event","value":"incurrence"}],"fact_type":"debt_financing"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}